Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial

Results

Title:	Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial
Authors:	Adkins Douglas R; Lin Jin-Ching; Sacco Assuntina; Ley Jessica; Oppelt Peter; Vanchenko Vyacheslay; Komashko Nataliia; Yen Chia-Jui; Wise-Draper Trisha; Gonzalez Jose L-P; Radulović Siniša; Shen Qi; Thurm Holger; Martini Jean-François; Hoffman Justin; Huang Xin; Melichar Bohuslav; Tahara Makoto;
Issue Date:	2021
Publication:	Oral Oncol 115 105192
ISSN:	0928-4931 Materials Science and Engineering. C: Materials for Biological Applications Search Idenfier
Type:	Report works
Collation:	vol. 115 str. 105192-105192
DOI:	10.1016/j.oraloncology.2021.105192
WoS-ID:	000636451300014
Scopus-ID:	2-s2.0-85100472072
PMID:	33571736
URI:	https://zenodo.org/record/5236182 https://enauka.gov.rs/handle/123456789/597574
Project:	issn:0928-4931 pmid:33571736
M-category:	Mp. category will be shown later

36
SCOPUS^TM

21
PubMed Central^TM

11
OpenCitations

36
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall

Google Scholar^TM